Overview

Detailed Summary

Welcure Drugs And Pharmaceuticals (WDPL) is engaged in the manufacture of bulk drugs and pharmaceutical formulations, including antibiotics and vitamins, offering over a hundred varieties of products.
The company has a strategic collaboration agreement with a Russian firm to be the sole selling agent for Stevioside, a sugar substitute, enhancing its portfolio and market reach.
Welcure has diversified its product line by adding sections for paediatric and veterinary drugs, as well as expanding into ointments and liquid syrups.
It boasts a strong infrastructure with a new liquid oral plant and ISO 9002 certification, ensuring high quality and standards for its products.

Sector: Pharmaceuticals
Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln M/S
Market Cap: 37 Cr
Volatility: Moderate Risk
P/E Ratio: 0.7
Industry P/E: 27.5
PEG Ratio: 0.0
P/B Ratio: 0.3
52W High: 1.44
52W Low: 0.28

Sales CAGR

1Y: 4.05%
3Y: 516.06%
5Y: 212.41%
10Y: 84.35%

Profit CAGR

1Y: -124.42%
3Y: 351.49%
5Y: —
10Y: 43.25%

ROE

TTM: 25.60%
3Y: 1.99%
5Y: 2.06%
10Y: 2.14%

ROCE

TTM: 17.53%
3Y: 1.18%
5Y: 1.22%
10Y: 1.26%

Technicals

‌

Forecasts

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
WALPAR	45.50	43 Cr	18.35	2.58	0.00	13.13	15.92	5.36
RAJNISH	0.41	42 Cr	-23.34	0.38	0.00	-0.10	0.05	-0.90
LASA	7.65	38 Cr	-0.87	0.68	0.00	0.87	-11.71	-61.75
VRL	120.00	38 Cr	10.03	0.98	1.67	11.58	14.72	7.89
WELCURE	0.30	37 Cr	0.72	0.28	0.00	25.60	17.53	5.59
ANG	23.99	31 Cr	-2.58	0.53	0.00	-20.68	-5.35	-4.84
CBPL	39.50	30 Cr	34.65	0.99	0.00	2.04	5.91	0.70

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales	0.00	0.00	0.00	0.00	25	8.84	21	300	66	0.00
Expenses	0.09	0.05	0.05	0.35	23	7.92	21	269	54	0.03
Operating Profit	-0.09	-0.05	-0.05	-0.35	1.85	0.92	0.64	31	11	-0.03
OPM %	—	—	—	—	7.54	10.41	3.02	10.38	17.31	—
Other Income	0.00	0.04	0.06	0.00	0.00	0.00	1.91	0.00	0.00	1.46
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.01	0.01	0.02	0.00	0.01	0.00	0.01	0.00	0.00	0.01
Profit Before Tax	-0.10	-0.03	-0.02	-0.35	1.84	0.91	2.54	31	11	1.43
Tax %	0.00	0.00	0.00	0.00	0.00	54.95	0.00	25.18	25.18	25.17
Net Profit	-0.10	-0.03	-0.02	-0.35	1.84	0.41	2.54	23	8.50	1.07
EPS in Rs	-0.00	-0.00	-0.00	-0.00	0.00	0.00	0.03	0.19	0.07	0.13

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	0.09	0.05	0.08	0.08	0.13	0.11	0.00	0.00	25	355
Expenses	0.06	0.07	0.08	0.09	0.08	0.08	0.13	0.23	24	320
Operating Profit	0.03	-0.02	0.00	-0.01	0.05	0.02	-0.13	-0.23	0.88	35
OPM %	30.80	-41.20	2.80	-11.76	41.19	22.46	—	—	3.58	9.74
Other Income	0.00	0.00	0.00	0.00	0.00	0.00	0.24	0.09	1.91	NaN
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.04	0.01	0.02
Profit Before Tax	0.03	-0.02	0.00	-0.01	0.06	0.02	0.10	-0.17	2.78	36
Tax %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	21.94	22.89
Net Profit	0.03	-0.02	0.00	-0.01	0.06	0.02	0.10	-0.17	2.17	28
EPS in Rs	0.00	-0.00	0.00	0.00	0.00	0.00	0.00	-0.00	0.03	0.42
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	12	12	12	12	12	12	12	13	13	112
Reserves	-12	-12	-12	-12	-12	-12	-12	-12	-12	-9.93
Borrowings	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	123
Other Liabilities	0.00	0.00	0.00	0.01	0.01	0.00	0.00	0.01	0.03	41
Total Liabilities	0.02	0.04	0.02	0.03	0.02	0.07	0.10	1.53	1.37	267
Fixed Assets	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.06	0.02	0.03
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.17	0.00	0.00
Other Assets	0.02	0.04	0.02	0.03	0.02	0.07	0.10	1.31	1.35	267
Total Assets	0.02	0.04	0.02	0.03	0.02	0.07	0.10	1.53	1.37	267

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	-0.05	0.02	-0.01	0.00	-0.01	0.04	0.02	0.11	-0.13	-222
Cash from Investing Activity	0.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.17	-0.06
Cash from Financing Activity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.17	-0.02	222
Net Cash Flow	-0.02	0.02	-0.01	0.00	-0.01	0.04	0.02	-0.06	0.02	0.11

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoters	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	99.99%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Total Shareholders	29,013	29,251	29,593	29,957	31,530	31,045	30,218	30,605	32,366	37,298	76,954	87,288

Market Transactions

Unlock Premium Features

Analyst Target, Price, EPS and Revenue Projections

Upgrade

Projection

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

Ask AI

Frequently Asked Questions about Welcure Drugs & Pharmaceuticals Ltd

Welcure Drugs & Pharmaceuticals Ltd (WELCURE) is currently trading at 0.30 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Welcure Drugs And Pharmaceuticals (WDPL) is engaged in the manufacture of bulk drugs and pharmaceutical formulations, including antibiotics and vitamins, offering over a hundred varieties of products. The company has a strategic collaboration agreement with a Russian firm to be the sole selling agent for Stevioside, a sugar substitute, enhancing its portfolio and market reach. Welcure has diversified its product line by adding sections for paediatric and veterinary drugs, as well as expanding into ointments and liquid syrups. It boasts a strong infrastructure with a new liquid oral plant and ISO 9002 certification, ensuring high quality and standards for its products.

Over the past 52 weeks, Welcure Drugs & Pharmaceuticals Ltd has traded between a low of ₹0.28 and a high of ₹1.44. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Welcure Drugs & Pharmaceuticals Ltd has a market capitalization of approximately 37.08. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Welcure Drugs & Pharmaceuticals Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 0.72 and operates in the Pharmaceuticals sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 37.08 Cr, Welcure Drugs & Pharmaceuticals Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Welcure Drugs & Pharmaceuticals Ltd operates in the Pharmaceuticals sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Welcure Drugs & Pharmaceuticals Ltd is 0.72. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

The 'Biopharma Shakti' scheme, with a ₹10,000 crore outlay, is the most significant announcement. It aims to boost domestic pharma manufacturing and streamline regulatory approvals through a strengthened CDSCO, benefiting the entire sector.

Welcure Drugs Pharmaceuticals Ltd

Stock Summary and Key Metrics

Investment Checklist

Investment Checklist

Overview

Financial Ratios

Technicals

Forecasts

Peers

Price Chart Comparison

Financial Statements

AI Powered Summary

Ask AI

Standalone Quarterly Results (in ₹ Crores)

Standalone Profit Loss (in ₹ Crores)

Standalone Balance Sheet (in ₹ Crores)

Standalone Cash Flows (in ₹ Crores)

Shareholdings

Shareholding History

Market Transactions

Unlock Premium Features

Upgrade

Projection

Documents

Actions

Announcements

AI Mode

Ask AI

Frequently Asked Questions about Welcure Drugs & Pharmaceuticals Ltd

What is Welcure Drugs & Pharmaceuticals Ltd share price today?

What does Welcure Drugs & Pharmaceuticals Ltd do?

What is the 52-week high and low of Welcure Drugs & Pharmaceuticals Ltd?

What is the market capitalization of Welcure Drugs & Pharmaceuticals Ltd?

Should I consider investing in Welcure Drugs & Pharmaceuticals Ltd stock?

Is Welcure Drugs & Pharmaceuticals Ltd a large-cap, mid-cap, or small-cap stock?

Which sector does Welcure Drugs & Pharmaceuticals Ltd belong to and why does it matter?

What is the PE ratio of Welcure Drugs & Pharmaceuticals Ltd?

What is the biggest Union Budget 2026 announcement for Welcure Drugs?

Utility

Company

Technicals

Forecasts

Projection

Frequently Asked Questions about Welcure Drugs & Pharmaceuticals Ltd

What is Welcure Drugs & Pharmaceuticals Ltd share price today?

What does Welcure Drugs & Pharmaceuticals Ltd do?

What is the 52-week high and low of Welcure Drugs & Pharmaceuticals Ltd?

What is the market capitalization of Welcure Drugs & Pharmaceuticals Ltd?

Should I consider investing in Welcure Drugs & Pharmaceuticals Ltd stock?

Is Welcure Drugs & Pharmaceuticals Ltd a large-cap, mid-cap, or small-cap stock?

Which sector does Welcure Drugs & Pharmaceuticals Ltd belong to and why does it matter?

What is the PE ratio of Welcure Drugs & Pharmaceuticals Ltd?

What is the biggest Union Budget 2026 announcement for Welcure Drugs?

Oscillators

Bullish

Overall

Bearish

Moving Averages

Bearish

Overall

Bearish

Peers

Price Chart Comparison

Announcements

Overview

Financial Ratios

Investment Checklist